Status:

COMPLETED

Beta-Blocker Heart Attack Trial (BHAT)

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Arrhythmia

Cardiovascular Diseases

Eligibility:

All Genders

30-69 years

Phase:

PHASE3

Brief Summary

To determine whether the regular administration of the beta-blocker drug propranolol to people who had had at least one documented myocardial infarction would result in a significant reduction of mort...

Detailed Description

BACKGROUND: Survivors of a documented myocardial infarction are recognized as having a high risk of dying relative to the general population. Serious arrhythmias, occurring with or without evidence o...

Eligibility Criteria

Men and women, ages 30 to 69. Documented myocardial infarction.

Key Trial Info

Start Date :

September 1 1977

Trial Type :

INTERVENTIONAL

End Date :

October 1 1981

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00000492

Start Date

September 1 1977

End Date

October 1 1981

Last Update

July 12 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Beta-Blocker Heart Attack Trial (BHAT) | DecenTrialz